lobbying_activities: 2351870

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2351870	badd5570-c705-4e56-86b7-edfeae97ba4d	Q3	BURRELL INTERNATIONAL GROUP LLC	401103483	ACER THERAPEUTICS	2019	third_quarter	PHA	No specific legislative vehicles. Issues are, generally, orphan drug legislation, rare disease legislation, drug pricing policy	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2019-10-18T13:50:35.470000-04:00